Compile Data Set for Download or QSAR
maximum 50k data
Found 48 Enz. Inhib. hit(s) with all data for entry = 10489
TargetLarge envelope protein(Hepatitis B virus)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM540705(US11261190, Example 29)
Affinity DataEC50:  6nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLarge envelope protein(Hepatitis B virus)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM540700(US11261190, Example 24)
Affinity DataEC50:  4nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLarge envelope protein(Hepatitis B virus)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM540707((R)-methyl 6-(((S)-2-(4-acetylphenyl)-3-oxohexahyd...)
Affinity DataEC50:  4nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLarge envelope protein(Hepatitis B virus)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM540708(US11261190, Example 32)
Affinity DataEC50:  6nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLarge envelope protein(Hepatitis B virus)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM540709(US11261190, Example 33)
Affinity DataEC50:  25nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLarge envelope protein(Hepatitis B virus)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM540710(US11261190, Example 34)
Affinity DataEC50:  16nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLarge envelope protein(Hepatitis B virus)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM540711(US11261190, Example 35)
Affinity DataEC50:  8nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLarge envelope protein(Hepatitis B virus)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM540712(3-(3-((S)-7-(((R)-6-(2-chloro-4-fluorophenyl)-5-(m...)
Affinity DataEC50:  5nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLarge envelope protein(Hepatitis B virus)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM540713(US11261190, Example 38)
Affinity DataEC50:  15nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLarge envelope protein(Hepatitis B virus)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM540714(US11261190, Example 39)
Affinity DataEC50:  29nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLarge envelope protein(Hepatitis B virus)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM540715(2-(4-((S)-7-(((R)-6-(2-chloro-4-fluorophenyl)-5-(m...)
Affinity DataEC50:  71nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLarge envelope protein(Hepatitis B virus)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM540716(US11261190, Example 44)
Affinity DataEC50:  10nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLarge envelope protein(Hepatitis B virus)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM540717(US11261190, Example 45)
Affinity DataEC50:  8nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLarge envelope protein(Hepatitis B virus)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM540718(2-((tert-butoxycarbonyl)amino)-2-(4-((S)-7-(((R)-6...)
Affinity DataEC50:  22nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLarge envelope protein(Hepatitis B virus)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM540719((E)-3-(4-((S)-7-(((R)-6-(2-chloro-4-fluorophenyl)-...)
Affinity DataEC50:  3nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLarge envelope protein(Hepatitis B virus)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM540720(US11261190, Example 48)
Affinity DataEC50:  10nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLarge envelope protein(Hepatitis B virus)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM540721((R)-methyl 4-(2-chloro-4-fluorophenyl)-6-(((S)-2-(...)
Affinity DataEC50:  12nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLarge envelope protein(Hepatitis B virus)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM540722(US11261190, Example 50B)
Affinity DataEC50:  8nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLarge envelope protein(Hepatitis B virus)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM540723(US11261190, Example 51B)
Affinity DataEC50:  9nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLarge envelope protein(Hepatitis B virus)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM540724((E)-3-(2-((S)-7-(((R)-6-(2-chloro-4-fluorophenyl)-...)
Affinity DataEC50:  13nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLarge envelope protein(Hepatitis B virus)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM540725((E)-3-(4-((S)-7-(((R)-6-(2-chloro-4-fluorophenyl)-...)
Affinity DataEC50:  14nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLarge envelope protein(Hepatitis B virus)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM540726((E)-3-(4-((S)-7-(((R)-6-(2-chloro-4-fluorophenyl)-...)
Affinity DataEC50:  11nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLarge envelope protein(Hepatitis B virus)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM540727(US11261190, Example 55)
Affinity DataEC50:  9nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLarge envelope protein(Hepatitis B virus)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM540728(US11261190, Example 56)
Affinity DataEC50:  12nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLarge envelope protein(Hepatitis B virus)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM540729(US11261190, Example 57)
Affinity DataEC50:  12nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLarge envelope protein(Hepatitis B virus)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM540730(US11261190, Example 58B)
Affinity DataEC50:  14nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLarge envelope protein(Hepatitis B virus)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM540731(US11261190, Example 59B)
Affinity DataEC50:  15nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLarge envelope protein(Hepatitis B virus)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM540701(US11261190, Example 25)
Affinity DataEC50:  5nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLarge envelope protein(Hepatitis B virus)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM540702(US11261190, Example 26)
Affinity DataEC50:  8nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
Ligand InfoKEGGPC cidPC sid
In DepthDetails US Patent
TargetLarge envelope protein(Hepatitis B virus)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM540703(US11261190, Example 27)
Affinity DataEC50:  7nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
Ligand InfoKEGGPC cidPC sid
In DepthDetails US Patent
TargetLarge envelope protein(Hepatitis B virus)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM540704(US11261190, Example 28)
Affinity DataEC50:  5nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLarge envelope protein(Hepatitis B virus)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM540695(3-(4-((S)-7-(((R)-6-(2-chloro-4-fluorophenyl)-5-(m...)
Affinity DataEC50:  3nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLarge envelope protein(Hepatitis B virus)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM540696(3-(2-((S)-7-(((R)-6-(2-chloro-4-fluorophenyl)-5-(m...)
Affinity DataEC50:  5nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLarge envelope protein(Hepatitis B virus)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM540697(2-(4-(((S)-7-(((R)-6-(2-chloro-4-fluorophenyl)-5-(...)
Affinity DataEC50:  22nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
Ligand InfoKEGGPC cidPC sid
In DepthDetails US Patent
TargetLarge envelope protein(Hepatitis B virus)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM540698(US11261190, Example 22)
Affinity DataEC50:  5nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLarge envelope protein(Hepatitis B virus)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM540732(US11261190, Example 60B)
Affinity DataEC50:  4nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLarge envelope protein(Hepatitis B virus)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM540733(US11261190, Example 61B)
Affinity DataEC50:  5nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLarge envelope protein(Hepatitis B virus)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM540699(US11261190, Example 23)
Affinity DataEC50:  7nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLarge envelope protein(Hepatitis B virus)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM540686((2R,4S)-4-((S)-7-(((R)-6-(2-chloro-4-fluorophenyl)...)
Affinity DataEC50:  56nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLarge envelope protein(Hepatitis B virus)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM540687((2R)-2-(7-(((R)-6-(2-chloro-4-fluorophenyl)-5-(met...)
Affinity DataEC50:  32nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLarge envelope protein(Hepatitis B virus)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM540688(3-((S)-7-(((R)-6-(2-chloro-4-fluorophenyl)-5-(meth...)
Affinity DataEC50:  37nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLarge envelope protein(Hepatitis B virus)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM540689(3-(4-((S)-7-(((R)-6-(2-chloro-4-fluorophenyl)-5-(m...)
Affinity DataEC50:  4nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLarge envelope protein(Hepatitis B virus)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM540690(2-(4-((S)-7-(((R)-6-(2-chloro-4-fluorophenyl)-5-(m...)
Affinity DataEC50:  7nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
Ligand InfoKEGGPC cidPC sid
In DepthDetails US Patent
TargetLarge envelope protein(Hepatitis B virus)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM540691(2-(4-((S)-7-(((R)-6-(2-chloro-4-fluorophenyl)-5-(m...)
Affinity DataEC50:  5nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLarge envelope protein(Hepatitis B virus)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM540692(US11261190, Example 16)
Affinity DataEC50:  14nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLarge envelope protein(Hepatitis B virus)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM540693(3-(4-((S)-7-(((R)-6-(2-chloro-4-fluorophenyl)-5-(m...)
Affinity DataEC50:  4nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLarge envelope protein(Hepatitis B virus)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM540694(3-(4-((S)-7-(((R)-6-(2-chloro-4-fluorophenyl)-5-(m...)
Affinity DataEC50:  4nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent
TargetLarge envelope protein(Hepatitis B virus)
Sunshine Lake Pharma

US Patent
LigandPNGBDBM540706(US11261190, Example 30)
Affinity DataEC50:  12nMAssay Description:8000 HepG 2.2.15 cells per well were seeded into a 96-well plate, the plate was cultured at 37° C. and 5% CO2 for 3 days till the cells grew to full ...More data for this Ligand-Target Pair
Ligand InfoPC cidPC sid
In DepthDetails US Patent